ETR:HNL Dr. Hönle (HNL) Stock Price, News & Analysis €13.90 -0.90 (-6.08%) (As of 09/6/2024 ET) Add Compare Share Share Today's Range€13.75▼€14.7050-Day Range€14.80▼€18.0552-Week Range€15.00▼€21.20Volume5,261 shsAverage VolumeN/AMarket Capitalization$84.23 millionP/E RatioN/ADividend Yield1.44%Price TargetN/A Stock AnalysisStock AnalysisChartHeadlinesStock AnalysisChartHeadlines Get Dr. Hönle alerts: Email Address Ad Timothy SykesTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT about Trump or Biden dropping out of the race…Click here to see a unique election-year trade About Dr. Hönle Stock (ETR:HNL)Dr. Hönle AG engages in the supply of industrial UV technologies and systems in Germany and internationally. The company operates through three segments: Adhesives, Equipment & Systems, and Glass & Lamps. The Adhesives segment provides industrial adhesives for applications, such as consumer electronics, automotive, optics and opto-electronics, medical technology, and glass processing. The Equipment & Systems segment engages in the provision of solutions used for drying inks and coatings, curing adhesives and plastics, disinfecting surfaces, and solar simulation. The Glass & Lamps segment offers quartz glass tubing and rods for the lamp, automotive, semiconductor, and fibre cable industries, as well as lamps for water disinfection, and the drying of coatings and adhesives. The company was founded in 1976 and is headquartered in Munich, Germany.Read More HNL Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart HNL Stock News HeadlinesSeptember 2, 2024 | finance.yahoo.comDr. Hönle AG's (ETR:HNL) top owners are individual investors with 52% stake, while 25% is held by private companiesAugust 27, 2024 | finance.yahoo.com3 German Stocks Estimated To Be Undervalued In August 2024September 7, 2024 | Porter & Company (Ad)The death of Nvidia?Today, I’m warning of another looming catastrophe. Only this time, it’s not in pot stocks, cryptos, or U.S. housing… it's in artificial intelligence. And unless you know what’s really going on in this sector, you could be wiped out. You see, while there is no doubt that the recent advancements in artificial intelligence are game-changing and will drive colossal innovation in every sector of the economy... There's also no escaping that The Big AI Die-Up is coming.August 15, 2024 | finance.yahoo.comMitsubishi Electric Corporation (MIE.F)August 15, 2024 | finance.yahoo.com3 German Stocks With Estimated Discounts Up To 26.9%August 9, 2024 | uk.finance.yahoo.comDr Hoenle AG (HNL.DU)July 25, 2024 | markets.businessinsider.comHNL Lab Medicine Opens Gilbertsville LocationMay 29, 2024 | finance.yahoo.comAre Investors Undervaluing Dr. Hönle AG (ETR:HNL) By 39%?September 7, 2024 | Porter & Company (Ad)The death of Nvidia?Today, I’m warning of another looming catastrophe. Only this time, it’s not in pot stocks, cryptos, or U.S. housing… it's in artificial intelligence. And unless you know what’s really going on in this sector, you could be wiped out. You see, while there is no doubt that the recent advancements in artificial intelligence are game-changing and will drive colossal innovation in every sector of the economy... There's also no escaping that The Big AI Die-Up is coming.May 26, 2024 | msn.comHawaii’s only no-cost dental clinic slated to close after 22 years of serviceMay 18, 2024 | msn.comHonolulu Hale will take on a new look soonMay 17, 2024 | msn.comAirline struggling to fulfill its role as Molokai’s lifeline to health careMay 10, 2024 | finance.yahoo.comWhat Is Dr. Hönle AG's (ETR:HNL) Share Price Doing?April 29, 2024 | finanznachrichten.dePTA-Adhoc: Dr. Hönle AG: Anpassung des Ausblicks für das Geschäftsjahr 2023/24April 22, 2024 | finance.yahoo.comShareholders in Dr. Hönle (ETR:HNL) are in the red if they invested five years agoApril 18, 2024 | finanznachrichten.dePTA-AFR: Dr. Hönle AG: Vorabbekanntmachung über die Veröffentlichung von Finanzberichten gemäß §§ 114-117 WpHGMarch 25, 2024 | finance.yahoo.comDr. Hönle AG's (ETR:HNL) top owners are retail investors with 54% stake, while 25% is held by private companiesFebruary 27, 2024 | finance.yahoo.comDr. Hönle First Quarter 2024 Earnings: €0.15 loss per share (vs €0.26 profit in 1Q 2023)See More Headlines Receive HNL Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Dr. Hönle and its competitors with MarketBeat's FREE daily newsletter. Email Address Industry, Sector and Symbol Stock ExchangeETR SectorIndustrials Industry Electrical Equipment & Parts Sub-IndustryN/A Current SymbolETR:HNL CUSIPN/A CIKN/A Webwww.hoenle.de Phone49 89 85608 0FaxN/AEmployees581Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)(€0.91) Trailing P/E RatioN/A Forward P/E Ratio9.72 P/E Growth-0.39Net Income$-5,370,000.00 Net Margins-5.45% Pretax MarginN/A Return on Equity-5.51% Return on Assets4.56% Debt Debt-to-Equity Ratio59.06 Current Ratio1.98 Quick Ratio0.85 Sales & Book Value Annual Sales$98.69 million Price / Sales0.85 Cash Flow€0.71 per share Price / Cash Flow19.54 Book Value€15.43 per share Price / Book0.90Miscellaneous Outstanding Shares6,060,000Free FloatN/AMarket Cap$84.23 million OptionableNot Optionable Beta1.49 Ten Starter Stocks For Beginners to Buy NowJust getting into the stock market? These 10 simple stocks can help beginning investors build long-term wealth without knowing options, technicals, or other advanced strategies.Get This Free Report Key ExecutivesDr. Franz Richter (Age 69)Chairman of the Management Board, MD & CEO Comp: $374.4kPeter WeinertHead of Investor RelationsKey CompetitorsVartaETR:VAR1LeoniETR:LEOHeidelberger Druckmaschinen AktiengesellschaftETR:HDDAumannETR:AAGBAUER AktiengesellschaftETR:B5AView All Competitors HNL Stock Analysis - Frequently Asked Questions How have HNL shares performed this year? Dr. Hönle's stock was trading at €17.50 at the beginning of the year. Since then, HNL stock has decreased by 20.6% and is now trading at €13.90. View the best growth stocks for 2024 here. This page (ETR:HNL) was last updated on 9/7/2024 by MarketBeat.com Staff From Our PartnersPerfect Crypto Buying Opportunity for 50 CentsWhen cryptos take a hit, the mom and pop investors run for the hills. But the top investors keep buying wit...Crypto 101 Media | SponsoredThe solution to fast food’s wage hike crisisShake Shack will be closing six California locations in response to the recent $20/hour minimum wage increase,...Deal Maker | SponsoredPre-IPO| 32,481% Growth: First Disruption to $martphones in 15 Years🤳45M Users | 32,481% Growth Rate Get in on the biggest disruption to smartphones in over a decade. Reg A inv...Mode Mobile | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredBiden’s Capital Gains Tax to Devastate Savings!Don't let the corrupt elites dictate your future—ACT NOW! This guide is your first step towards financial inde...Golden Crest | SponsoredSay Goodbye to the US DollarThe warning signs are everywhere… According to experts, the United States Dollar is "as good as doomed." ...Sasco Gold LLC | SponsoredChina Stockpiling Gold “Like No Tomorrow”For 18 consecutive months, China’s central bank has increased its gold reserve. The country, with a populat...True Gold Republic | SponsoredTrump’s weapon lurks in abandoned AmericaUnemployment is sky-high, wages are at record lows. Addiction has overwhelmed these once thriving coal towns. ...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Dr. Hönle AG Please log in to your account or sign up in order to add this asset to your watchlist. Share Dr. Hönle With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.